A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment | Antimicrobial Agents and Chemotherapyhttps://aac.asm.org/content/early/2019/10/01/AAC.01637-19/article-info
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment
Fast-Food and Beef Industries Are Still Fueling Scary Superbugs | NRDChttps://www.nrdc.org/experts/lena-brook/fast-food-and-beef-industries-are-still-fueling-scary-superbugs
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatmentFast food
Here's How Bad Antibiotic Resistance Has Gotten in the Past 20 Yearshttps://www.healthline.com/health-news/heres-how-bad-antibiotic-resistance-has-gotten
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment
Here’s How Bad Antibiotic Resistance Has Gotten Over the Past 20 Years - EcoWatchhttps://www.ecowatch.com/antibiotic-resistance-2641061326.html
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment
It Took Just Three Weeks for Superbug to Resist Last-Resort Drug, Doctors Sayhttps://gizmodo.com/it-took-just-three-weeks-for-superbug-to-resist-last-re-1839236816
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment
Oh, good: An antibiotic-resistant germ evolved to beat a ‘last resort’ drug in less than a month – BGRhttps://bgr.com/2019/10/22/drug-resistant-bacteria-antibiotic-treatment/
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment
Resistance to last resort drug arose in patient over 3 weekshttps://medicalxpress.com/news/2019-10-resistance-resort-drug-arose-patient.html
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatmentCeftolozane-tazobactamCephalosporinasesPiperacillin-tazobactam
Resistance to last resort drug arose in patient over 3 weeks -- ScienceDailyhttps://www.sciencedaily.com/releases/2019/10/191021135035.htm
2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment

Showing topic

2019-10 A 2.5-years within-patient evolution of a Pseudomonas aeruginosa with in vivo acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment
Drug-resistant Pseudomonas aeruginosa